# FULC (Fulcrum Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Fulcrum Therapeutics, Inc. reported $0 in revenue and a net loss of $76.34M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/FULC
- Markdown: https://convexityos.com/fundamentals/FULC.md
- SEC CIK: 0001680581
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:41 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001680581&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$88.05M | Operating profit |
| Net Income | FY 2025 | -$76.34M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.00 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$65.24M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $116.4M | Total debt: $6.83M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $80.00M | $2.81M | $6.34M | $19.16M | $8.82M | -- | -- |
| Research & Development | $56.10M | $63.39M | $71.80M | $76.78M | $69.70M | $59.04M | $71.07M | $25.18M |
| Total Operating Expenses | $84.77M | $101.9M | $113.5M | $118.9M | $100.2M | $80.43M | $84.22M | $33.50M |
| **Operating Income** | -$84.77M | -$21.90M | -$110.7M | -$112.6M | -$81.05M | -$71.61M | -$84.22M | -$33.50M |
| **EBITDA** | -$83.38M | -$20.30M | -$108.5M | -$110.1M | -$78.54M | -$69.23M | -$82.16M | -$32.15M |
| Income Tax Expense | $0 | $0 | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$74.88M | -$9.72M | -$97.33M | -$109.9M | -$80.85M | -$70.82M | -$82.68M | -$32.59M |
| Basic EPS | -$1.18 | -$0.16 | -$1.59 | -$2.44 | -$2.29 | -$2.79 | -$8.13 | -$31.14 |
| **Diluted EPS** | -$1.18 | -$0.16 | -$1.59 | -$2.44 | -$2.29 | -$2.79 | -$8.13 | -$31.14 |
| Basic Shares Outstanding | 63.4K | 62.0K | 61.3K | 45.0K | 35.4K | 25.4K | 11.0K | 1.3K |
| Diluted Shares Outstanding | 63.4K | 62.0K | 61.3K | 45.0K | 35.4K | 25.4K | 11.0K | 1.3K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | $0 | $0 | -- | $0 |
| Research & Development | $3.03M | $12.44M | $14.08M | $15.42M | $14.30M | $12.99M | $13.40M | $11.71M |
| Total Operating Expenses | $13.86M | $29.31M | $22.19M | $22.69M | $21.86M | $19.82M | $20.40M | $19.43M |
| **Operating Income** | -$13.86M | -$29.31M | -$22.19M | -$22.69M | -$21.86M | -$19.82M | -$20.40M | -$19.43M |
| **EBITDA** | -$13.56M | -$29.11M | -$21.85M | -$22.35M | -$21.56M | -$19.52M | -$20.05M | -$19.06M |
| **Net Income** | -$10.94M | -$26.18M | -$18.89M | -$20.33M | -$19.59M | -$17.30M | -$17.66M | -$16.57M |
| Basic EPS | -$0.14 | -$0.34 | -$0.25 | -- | -$0.31 | -$0.28 | -$0.28 | -- |
| **Diluted EPS** | -$0.14 | -$0.34 | -$0.25 | -- | -$0.31 | -$0.28 | -$0.28 | -- |
| Basic Shares Outstanding | 76.3M | 76.3M | 76.2M | -- | 62.6M | 62.5M | 62.5M | -- |
| Diluted Shares Outstanding | 76.3M | 76.3M | 76.2M | -- | 62.6M | 62.5M | 62.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $197.5M | $58.21M | $25.56M | $35.10M | $35.41M | $57.05M | $96.71M | $72.80M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | $0 | -- |
| **Cash & Short-Term Investments** | $197.5M | $58.21M | $25.56M | $35.10M | $35.41M | $57.05M | $96.71M | $72.80M |
| Other Current Assets | -- | -- | -- | -- | $0 | $74K | $284K | $238K |
| **Total Current Assets** | $357.5M | $249.9M | $242.2M | $207.5M | $226.0M | $119.5M | $100.1M | $74.09M |
| Property, Plant & Equipment, Net | $2.82M | $3.90M | $5.22M | $6.91M | $7.37M | $8.40M | $9.21M | $10.55M |
| Other Non-Current Assets | $538K | $10K | $2.01M | $2.10M | $542K | $578K | $59K | $38K |
| **Total Non-Current Assets** | $8.80M | $10.79M | $15.49M | $19.17M | $9.00M | $10.07M | $10.36M | $11.68M |
| **Total Assets** | $366.3M | $260.7M | $257.7M | $226.7M | $235.0M | $129.6M | $110.4M | $85.77M |
| Accounts Payable | $1.59M | $1.16M | $2.76M | $3.64M | $4.79M | $4.08M | $2.19M | $1.26M |
| Deferred Revenue (Current) | -- | -- | $0 | $934K | $4.71M | $14.91M | $3.99M | -- |
| Other Current Liabilities | $258K | $463K | $396K | $105K | $74K | $44K | $49K | $120K |
| **Total Current Liabilities** | $13.05M | $11.04M | $13.68M | $16.73M | $19.20M | $26.73M | $12.14M | $4.23M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | $1.68M | $2.97M | $6.01M | -- |
| Other Non-Current Liabilities | $197K | $197K | $197K | $197K | $0 | -- | $55K | $150K |
| **Total Non-Current Liabilities** | $4.24M | $6.64M | $8.83M | $11.02M | $4.26M | $7.67M | $11.15M | $5.54M |
| **Total Liabilities** | $17.28M | $17.68M | $22.50M | $27.74M | $23.46M | $34.40M | $23.29M | $9.77M |
| **Total Debt (incl. Leases)** | $6.44M | $8.63M | $10.82M | $13.42M | -- | -- | -- | -- |
| Common Stock | $67K | $54K | $62K | $52K | $41K | $28K | $23K | $2.0K |
| Retained Earnings | -$594.3M | -$519.4M | -$509.7M | -$412.3M | -$302.5M | -$221.6M | -$150.8M | -$68.12M |
| Accumulated Other Comp. Income | $174K | $130K | -$136K | -$797K | -$397K | -$2.0K | -- | -- |
| **Total Stockholders' Equity** | $349.0M | $243.0M | $235.2M | $198.9M | $211.5M | $95.18M | $87.15M | -$63.67M |
| Total Equity | $349.0M | $243.0M | $235.2M | $198.9M | $211.5M | $95.18M | $87.15M | -$63.67M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $116.4M | $48.47M | $50.26M | $197.5M | $47.08M | $42.59M | $42.18M | $58.21M |
| **Cash & Short-Term Investments** | $116.4M | $48.47M | $50.26M | $197.5M | $47.08M | $42.59M | $42.18M | $58.21M |
| Other Current Assets | -- | -- | -- | -- | -- | $69K | -- | -- |
| **Total Current Assets** | $310.8M | $322.9M | $338.7M | $357.5M | $205.9M | $219.4M | $232.6M | $249.9M |
| Property, Plant & Equipment, Net | $0 | $0 | $2.49M | $2.82M | $3.17M | $3.27M | $3.55M | $3.90M |
| Other Non-Current Assets | $9.0K | $9.0K | $546K | $538K | $9.0K | $12K | $10K | $10K |
| **Total Non-Current Assets** | $9.0K | $1.10M | $8.10M | $8.80M | $8.99M | $9.46M | $10.09M | $10.79M |
| **Total Assets** | $310.8M | $324.0M | $346.8M | $366.3M | $214.9M | $228.8M | $242.6M | $260.7M |
| Accounts Payable | $509K | $3.42M | $2.45M | $1.59M | $2.86M | $1.75M | $1.51M | $1.16M |
| Other Current Liabilities | $126K | $174K | $308K | $258K | $236K | $173K | $441K | $463K |
| **Total Current Liabilities** | $8.59M | $10.30M | $9.86M | $13.05M | $11.63M | $8.98M | $8.10M | $11.04M |
| Other Non-Current Liabilities | $197K | $197K | $197K | $197K | $197K | $197K | $197K | $197K |
| **Total Non-Current Liabilities** | $197K | $2.96M | $3.60M | $4.24M | $4.86M | $5.47M | $6.06M | $6.64M |
| **Total Liabilities** | $8.78M | $13.26M | $13.47M | $17.28M | $16.49M | $14.46M | $14.16M | $17.68M |
| **Total Debt (incl. Leases)** | $6.83M | $5.28M | $5.87M | $6.44M | $7.01M | $7.57M | $8.11M | $8.63M |
| Common Stock | $76K | $76K | $67K | $67K | $54K | $54K | $54K | $54K |
| Retained Earnings | -$650.3M | -$639.3M | -$613.2M | -$594.3M | -$573.9M | -$554.3M | -$537.1M | -$519.4M |
| Accumulated Other Comp. Income | -$759K | -$567K | -$513K | $174K | $241K | $82K | $70K | $130K |
| **Total Stockholders' Equity** | $302.0M | $310.7M | $333.3M | $349.0M | $198.4M | $214.4M | $228.5M | $243.0M |
| Total Equity | $302.0M | $310.7M | $333.3M | $349.0M | $198.4M | $214.4M | $228.5M | $243.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$74.88M | -$9.72M | -$97.33M | -$109.9M | -$80.85M | -$70.82M | -$82.68M | -$32.59M |
| Depreciation & Amortization | $1.39M | $1.59M | $2.17M | $2.41M | $2.52M | $2.38M | $2.05M | $1.34M |
| Stock-Based Compensation | $12.47M | $14.55M | $14.80M | $13.35M | $11.07M | $7.35M | $4.22M | $2.16M |
| Change in Receivables | $2.10M | -$1.56M | -$308K | $908K | -$606K | $531K | -- | -- |
| Change in Payables | $428K | -$1.59M | -$853K | -$1.18M | $973K | $1.77M | $803K | -$20K |
| **Operating Cash Flow** | -$60.06M | -$2.22M | -$90.97M | -$97.05M | -$78.48M | -$53.66M | -$39.48M | -$22.56M |
| Capital Expenditure | -$314K | -$278K | -$508K | -$1.96M | -$1.71M | -$1.34M | -$853K | -$8.98M |
| **Free Cash Flow** | -$60.38M | -$2.50M | -$91.47M | -$99.01M | -$80.19M | -$55.00M | -$40.34M | -$31.54M |
| Purchases of Investments | -$180.2M | -$178.6M | -$194.9M | -$151.2M | -$216.2M | -$124.3M | -- | -- |
| **Investing Cash Flow** | $30.72M | $32.23M | -$36.69M | $12.41M | -$129.7M | -$57.14M | -$944K | -$8.98M |
| Common Stock Issued | $4.17M | $2.75M | $777K | $3.52M | $3.67M | $1.43M | $249K | $12K |
| **Financing Cash Flow** | $168.7M | $2.75M | $118.1M | $84.32M | $186.5M | $71.13M | $64.34M | $105.0M |
| **Net Change in Cash** | $139.3M | $32.76M | -$9.54M | -$314K | -$21.64M | -$39.66M | $23.92M | $73.48M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$10.94M | -$26.18M | -$18.89M | -$20.33M | -$19.59M | -$17.30M | -$17.66M | -$16.57M |
| Depreciation & Amortization | $300K | $200K | $338K | $347K | $300K | $300K | $353K | $369K |
| Stock-Based Compensation | $2.17M | $3.27M | $3.86M | $3.07M | $3.36M | $2.88M | $3.17M | $2.48M |
| Change in Receivables | $0 | $0 | $0 | $0 | $0 | $979K | $1.12M | $1.56M |
| Change in Payables | -$2.92M | $975K | $858K | -$1.10M | $946K | $244K | $343K | -$2.70M |
| **Operating Cash Flow** | -$13.38M | -$16.04M | -$18.75M | -$16.80M | -$14.19M | -$13.82M | -$15.26M | -$16.76M |
| Capital Expenditure | $0 | -$108K | -$8.0K | -$159K | -$90K | -$65K | $0 | -$231K |
| **Free Cash Flow** | -$13.38M | -$16.15M | -$18.76M | -$16.96M | -$14.28M | -$13.88M | -$15.26M | -$16.99M |
| Purchases of Investments | $0 | -$24.22M | -$155.3M | -$26.14M | -$17.29M | -$76.39M | -$60.40M | -$21.41M |
| **Investing Cash Flow** | $81.13M | $13.78M | -$128.2M | -$1.05M | $18.61M | $13.93M | -$777K | $2.26M |
| Common Stock Issued | $198K | $356K | $21K | $3.80M | $64K | $301K | $0 | $83K |
| **Financing Cash Flow** | $198K | $356K | -$312K | $168.3M | $64K | $301K | $0 | $83K |
| **Net Change in Cash** | $67.94M | -$1.90M | -$147.3M | $150.5M | $4.49M | $414K | -$16.03M | -$14.42M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -27.4% | -3945.2% | -1774.9% | -423.0% | -811.6% | -- | -- |
| **Net Profit Margin** | -- | -12.2% | -3470.1% | -1732.4% | -421.9% | -802.7% | -- | -- |
| Return on Equity (ROE) | -21.5% | -4.0% | -41.4% | -55.2% | -38.2% | -74.4% | -94.9% | -- |
| Return on Assets (ROA) | -20.4% | -3.7% | -37.8% | -48.5% | -34.4% | -54.7% | -74.9% | -38.0% |
| Current Ratio | 27.40x | 22.63x | 17.71x | 12.41x | 11.77x | 4.47x | 8.24x | 17.52x |
| Quick Ratio | 15.14x | 5.27x | 1.87x | 2.10x | 1.84x | 2.13x | 7.97x | 17.21x |
| Debt to Equity | 0.02x | 0.04x | 0.05x | 0.07x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -100.0% | +2752.0% | -55.8% | -66.9% | +117.2% | -- | -- | -- |
| 5Y Revenue / Share Growth | -100.0% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -27.4% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -12.2% |
| Return on Equity (ROE) | -25.3% | -27.4% | -22.8% | -21.5% | -35.8% | -34.2% | -0.2% | -4.0% |
| Return on Assets (ROA) | -24.6% | -26.2% | -21.9% | -20.4% | -33.1% | -32.0% | -0.2% | -3.7% |
| Current Ratio | 36.19x | 31.35x | 34.33x | 27.40x | 17.70x | 24.42x | 28.71x | 22.63x |
| Quick Ratio | 13.56x | 4.71x | 5.10x | 15.14x | 4.05x | 4.74x | 5.21x | 5.27x |
| Debt to Equity | 0.02x | 0.02x | 0.02x | 0.02x | 0.04x | 0.04x | 0.04x | 0.04x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -100.0% | -- | -100.0% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -137.7% | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -131.2% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -131.5% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -123.5% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -123.6% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
